EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interleukin-11 Signaling in Liver Disease: Mechanisms, Cellular Crosstalk, and Therapeutic Potential

Zhiyuan Chen, Fan Yu, Yanhua Qiu, Jun Lin, Meilian Yu, Jinwei Yan, Xianzhi Liu

Biomolecules · 09.09.2026 · 16 (9) · 1309

DOI: 10.3390/biom16091309 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 09.09.2026. Verfasst von Zhiyuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China. Hauptthemen laut MEDLINE: Interleukin-11, Signal Transduction, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, Xiamen Health High Quality Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver has a remarkable regenerative capacity, but persistent injury caused by drugs, metabolic dysfunction, alcohol, and chronic inflammation can overwhelm this process and promote fibrosis and hepatocellular carcinoma. Interleukin-11 (IL-11), a cytokine that signals through glycoprotein 130 (gp130), was historically considered hepatoprotective; however, accumulating experimental evidence predominantly identifies endogenous IL-11 as an amplifier of liver injury and maladaptive repair. In hepatocytes, IL-11 promotes oxidative stress, mitochondrial dysfunction, and cell death while limiting effective regeneration. In hepatic stellate cells, it sustains myofibroblastic activation and extracellular matrix production, while crosstalk with hepatocytes, macrophages, and the matrix reinforces a fibroinflammatory niche. In hepatocellular carcinoma, experimental and associative clinical evidence implicates IL-11 in tumor growth, invasion, metastatic colonization, postoperative recurrence, stromal remodeling, and immune suppression. These findings have supported the development of therapeutic strategies targeting the IL-11/IL-11RA axis, with the potential to provide broad therapeutic benefits across a wide spectrum of liver diseases. This review summarizes IL-11 regulation and signaling in liver disease; discusses its roles in liver injury, fibrosis, and hepatocellular carcinoma; and evaluates the opportunities and challenges of IL-11-targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-11Signal TransductionLiver DiseasesHumansAnimalsLiver NeoplasmsHepatic Stellate CellsCarcinoma, Hepatocellular

Stichwörter der Autor:innen

cellular crosstalkinterleukin-11liver diseasetargeted therapy

Substanzen

Interleukin-11IL11 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
  • Department of Gastrointestinal Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.
  • Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Department of Pediatrics, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Fellowship Program of CPSF
  • Xiamen Health High Quality Development Project
  • Foundation for Cultivated Young Talents of Fujian Province, China
  • Fujian Provincial Health and Technology Program - Young and Middle-aged Key Talent Development Project
  • Young Investigator Research Program of Xiang'an Hospital of Xiamen University
  • Natural Science Foundation of Fujian Province
  • Fujian Provincial Health and Technology Program—Young and Middle-aged Key Talent Development Project

Zitieren

APA

Chen, Z., Yu, F., Qiu, Y., Lin, J., Yu, M., Yan, J., & Liu, X. (2026). Interleukin-11 Signaling in Liver Disease: Mechanisms, Cellular Crosstalk, and Therapeutic Potential. Biomolecules, 16(9), 1309. https://doi.org/10.3390/biom16091309

Vancouver

Chen Z, Yu F, Qiu Y, Lin J, Yu M, Yan J, et al. Interleukin-11 Signaling in Liver Disease: Mechanisms, Cellular Crosstalk, and Therapeutic Potential. Biomolecules. 2026;16(9):1309. doi:10.3390/biom16091309

BibTeX
@article{Chen2026,
  author = {Chen, Zhiyuan and Yu, Fan and Qiu, Yanhua and Lin, Jun and Yu, Meilian and Yan, Jinwei and Liu, Xianzhi},
  title = {Interleukin-11 Signaling in Liver Disease: Mechanisms, Cellular Crosstalk, and Therapeutic Potential},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {9},
  pages = {1309},
  doi = {10.3390/biom16091309}
}
Kostenlos starten →